CEDAR has expertise and experience in health economics, including critical appraisal of models, economic modelling, supporting evaluations and service change and Social Return on Investment (SROI).
Our Health economic work is led by Principal Health Economist Megan Dale, with additional expertise from Senior Health Economist Huey Yi Chong and support from the wider team. CEDAR is contracted by NICE to critique and amend company-submitted economic evaluations for the Medical Technologies Evaluation Programme. We also work with research teams to support clinical trials and support a number of different types of evaluations. CEDAR also provides lecturing to Cardiff University on several topics, including health economics.
CEDAR is an external assessment group for NICE, contributing primarily to the Medical Technologies Evaluation Programme (MTEP) with economic critique and modelling work.
CEDAR works with a range of clinical and academic partners to provide health economic analysis alongside research studies and also for smaller evaluations related to service change or interventions.
CEDAR has several staff trained in delivering Social Return on Investment (SROI) evaluations which are designed to enable the formal inclusion of social value in decision making.